Veracyte Secures NY State Approval for Genomic Classifier Test for Lung Disease

Apr 23, 2019

|

NEW YORK (GenomeWeb) – Veracyte has received regulatory approval from the New York State Department of Health to offer its Envisia Genomic Classifier test to patients in the state immediately, the company said on Monday. The test uses RNA sequencing and machine learning to help distinguish idiopathic pulmonary fibrosis (IPF) from other interstitial lung diseases (ILD) without surgery.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

Breaking News

The Scan

Swabs for Science of Spread

A study of families explores how children transmit SARS-CoV-2, according to the Associated Press.

Genome of the Murder Hornet

US Agricultural Research Service scientists have sequenced the genome of the Asian giant hornet.

In a Pool Together

According to the Economist, pooled testing for COVID-19 could help alleviate strains on testing labs.

Science Presents Paper on Computational Method to Predict IBD Patient Response to Therapy

In Science this week: MIT researchers outline approach dubbed translatable components regression to predict treatment response among IBD patients.

Featured White Papers

Compatibility of liquid biopsy assays on multiple sequencing platforms

Delivering Rapid Whole Genome Reports for ICU Cases with Opal Clinical STAT

White Paper: Using Single-Cell Multiomics to Reveal New Insights Into Uveal Melanoma Evolution and Therapeutic Resistance

AnyDeplete - A customizable depletion solution for RNA-Seq workflows

Aug

13

Featured Webinar

Single-Cell and Spatial Transcriptomic Profiling of the Septic Kidney

This webinar will discuss a study that combined single-cell gene expression and spatial gene expression to understand the evolution of sepsis in the kidney at the cellular and molecular level.

Aug

18

Featured Webinar

COVID-19 Wastewater-Based Epidemiology: Methods and Insights for SARS-CoV-2 Community Surveillance

As worldwide COVID-19 cases continue to rise, there is a significant need to increase testing and population surveillance capacity.

Aug

24

Featured Webinar

Utility of Novel RNA-Based Tools in Oncology Drug Development

This webinar, Part 1 of the “Advances in RNA-based Biomarker Development for Precision Oncology” webinar series sponsored by GeneCentric Therapeutics, will discuss how gene expression signatures can accelerate (and rehabilitate) drug programs, define targeted patient populations, expand drug indications, and improve clinical success.

Aug

26

Featured Webinar

Resolving Complex Haplotypes Implicated in Alzheimer’s and Other Neurodegenerative Diseases

Alzheimer’s disease is genetically complex with no meaningful therapies or pre-symptomatic disease diagnostics.

Menu

Veracyte Secures NY State Approval for Genomic Classifier Test for Lung Disease

To read the full story....

Breaking News

Guardant Health CDx Wins FDA Approval for First Liquid Biopsy NGS Tumor Profiling Assay

Researchers Use CRISPR-Cas13 Platform to Interrogate Gene Function in Animal Embryos

New Products Posted to GenomeWeb: Illumina, Adaptive Biotechnologies, Personalis, More

In Brief This Week: ArcherDx, NanoString Technologies, the Cleveland Clinic, and More

Bruker, Utrecht University Partnering on Mass Spec Methods

People in the News: New Appointments at Pacific Biosciences, Lexogen, Tangen Biosciences, More

The Scan

Swabs for Science of Spread

Genome of the Murder Hornet

In a Pool Together

Science Presents Paper on Computational Method to Predict IBD Patient Response to Therapy

Featured White Papers

Single-Cell and Spatial Transcriptomic Profiling of the Septic Kidney

COVID-19 Wastewater-Based Epidemiology: Methods and Insights for SARS-CoV-2 Community Surveillance

Utility of Novel RNA-Based Tools in Oncology Drug Development

Resolving Complex Haplotypes Implicated in Alzheimer’s and Other Neurodegenerative Diseases

What's Popular?

Illumina Q2 Revenues Drop 25 Percent

Rakuten Medical Sues Illumina Over Trademark Dispute

Blackstone to Acquire Ancestry for $4.7B

NHS Wales Introduces Whole-Genome Sequencing for Critically Ill Newborns, Children

Illumina Sees Expanding Sequencing Market in COVID-19 Response, Despite Short-Term Woes

Sponsorships